Age-related eye diseases, their treatment, and the latest research to find cures will take center stage at the 2007 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting to be held at the Greater Fort Lauderdale/Broward County Convention Center in Fort Lauderdale, Fla., May 6-10, 2007.
Over 10,000 registrants are expected to attend this year?s Meeting.
Highlighting this global issue will be the ARVO/Alcon Keynote Session on Sunday, May 6, featuring William Novelli, CEO of AARP, the leading nonprofit, nonpartisan membership organization for people age 50 and over in the United States. Novelli?s presentation is entitled ?Public Health Impact of Eye Disease in the Elderly: What Can Be Done About It.? In addition, Paul Lee, MD, JD, professor of ophthalmology at Duke University, will discuss cost-effective approaches to improving the vision and quality of life of those with major blinding eye diseases and will highlight specific areas in which the eye research community can have an impact.
?ARVO anticipates that this year?s Meeting will be a major forum to present the many efforts underway to unlock the mysteries surrounding eye diseases including age-related macular degeneration, glaucoma, cataracts, and diabetic eye disease,? said ARVO President Frederick L. Ferris III, MD.
The Annual Meeting will include over 6,000 paper and poster presentations. In addition, special recognition awards will be presented during the five-day meeting including:
Mildred Weisenfeld Award for Excellence in Ophthalmology
ARVO/Alcon Early Career Clinician-Scientist Research Awards
ARVO/Pfizer Ophthalmics Translational Research Awards
An all-time high of 132 organizations will be exhibiting at the Annual Meeting. To view a list of the national and international firms scheduled to feature their products and services at the ARVO Annual Meeting, logon to www.arvo.org/Exhibits.
Age-related eye diseases are the leading causes of vision impairment and blindness throughout the world. With the world?s population of seniors at an all-time high and still growing, addressing the issues of vision loss in the older population is, now more than ever, of paramount importance.